Keytruda is an immunotherapy protocol that has proven remarkably effective in treating many types of cancer, but attendees at an international cancer conference learned this week that a randomized phase 3 trial showed disappointing results in mesothelioma patients. ESMO Conference Attendees Hear Results of Keytruda Trials The European Society of Medical Oncology’s annual meeting has…
The post Conference Attendees Learn that Keytruda Yields Disappointing Mesothelioma Results appeared first on Mesothelioma.net.
from Mesothelioma.net https://ift.tt/2nfT87w
via IFTTT
Conference Attendees Learn that Keytruda Yields Disappointing Mesothelioma Results
![Conference Attendees Learn that Keytruda Yields Disappointing Mesothelioma Results]()
Reviewed by Unknown
on
October 01, 2019
Rating:
No comments: